Table 2 Baseline characteristics after PS matching

Age, yrs

72.7 ± 9.9

73.2 ± 9.3

0.591

Female, %

22.4

26.0

0.406

Diabetes mellitus, %

64.6

63.0

0.712

BMI, kg/m²

23.0 ± 3.5

23.3 ± 4.0

0.485

eGFR, ml/min/1.73 m²

6.4 ± 3.1

6.0 ± 2.5

0.062

Creatinine, mg/dL

7.85 ± 2.51

8.09 ± 2.45

0.260

BUN, mg/dL

88.2 ± 29.0

88.7 ± 29.1

0.862

Hemoglobin, g/dL

9.4 ± 1.4

9.3 ± 1.5

0.355

Albumin, g/dL

3.14 ± 0.58

3.16 ± 0.56

0.738

Uric acid, mg/dL

8.8 ± 2.7

8.5 ± 2.4

0.146

Potassium, mEq/L

4.5 ± 0.8

4.6 ± 0.9

0.238

Adjusted calcium, mg/dL

8.7 ± 0.9

8.6 ± 1.0

0.193

Phosphorus, mg/dL

5.7 ± 1.5

6.0 ± 1.7

0.050

LDL-cholesterol, mg/dL

83 ± 32

83 ± 33

0.992

HDL-cholesterol, mg/dL

41 ± 14

46 ± 17

0.003

Triglyceride, mg/dL

125 ± 96

111 ± 46

0.059

CRP, mg/dL

2.0 ± 3.3

2.0 ± 4.4

0.946

Use of ARBs or ACEIs, %

61.8

60.2

0.785

Use of β-blockers, %

55.9

48.4

0.109

Use of anti-platelet agents, %

74.0

28.7

<0.001

Use of warfarin, %

13.0

11.0

0.586

Use of loop diuretics, %

77.2

74.0

0.408

Use of statins, %

66.1

63.8

0.642

Use of ESAs

84.6

87.8

0.235